NDRA News
ENDRA Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update
ENDRA Life Sciences Inc. (NASDAQ: NDRA) (ENDRA or the Company), a pioneer in thermoacoustic biomarker imaging for early detection and monitoring of steatotic liver disease (SLD), reported financial results for the quarter ended June 30, 2026, and provided a business update. Second Quarter 2026 and...
Business Wire
ENDRA Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update
ENDRA Life Sciences Inc. (NASDAQ: NDRA) (ENDRA or the Company), a pioneer in thermoacoustic biomarker imaging for early detection and monitoring of steatotic liver disease (SLD), reported financial results for the quarter ended June 30, 2026, and provided a business update. Second Quarter 2026 and...
Business Wire
Gainers
ENDRA Life Sciences (NASDAQ:NDRA) shares rose 10.8% to $5.94 during Tuesday's after-market session. The market value of their outstanding shares is at $6.2 million.
Apimeds Pharmaceuticals (AMEX:APUS)read more...
Benzinga
ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes" or ASPI), an advanced materials company focused on developing technologies and processes for the production of critical materials used in multiple industries, and ENDRA Life Sciences Inc. (NASDAQ: NDRA) (ENDRA or NDRA), a pioneer in thermoacoustic...
Business Wire
SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--FSRL, SYNA, TECH, and NDRA SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--FSRL, SYNA, TECH, and NDRA PR Newswire NEW YORK, July 2, 2026 NEW YORK, July 2, 2026 /PRNewswire/ -- Class...
PR Newswire
Halper Sadeh LLC, an investor rights law firm, is investigating the merger of ENDRA Life Sciences Inc. (NASDAQ: NDRA) with Noble Africa LLC. Upon closing of the proposed transaction, ENDRA shareholders are expected to own approximately 3% of the combined company.Halper Sadeh encourages ENDRA...
Business Wire
ASP Isotopes is expected to own approximately 89% of the combined company, with ENDRA shareholders owning 3%.
ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes," ASPI or the "Company"), an advanced materials company focused on developing technologies and processes for the production of critical materials used in multiple industries, and ENDRA Life Sciences Inc. (NASDAQ: NDRA) (ENDRA or NDRA), a pioneer in...
Business Wire
ENDRA Life Sciences Inc. (NASDAQ: NDRA) (ENDRA or the Company), a pioneer in thermoacoustic biomarker imaging for early detection and monitoring of steatotic liver disease (SLD), today reported...
Business Wire
ENDRA Life Sciences Inc. (NASDAQ: NDRA) (ENDRA or the Company), a pioneer in thermoacoustic biomarker imaging for the early detection and monitoring of steatotic liver disease (SLD), today announced...
Business Wire
ENDRA Life Sciences Inc. (NASDAQ: NDRA) (ENDRA or the Company), a pioneer in thermoacoustic biomarker imaging for early detection and monitoring of steatotic liver disease (SLD), today reported...
Business Wire